Fahrenheit at a glance

On the 8th of August, 1988, several prominent doctors and surgeons believed that conventional drugs were lacking in potency and believed that only a quality drug will improve the welfare of mankind.

 

Concerned for their patients’ health and wellbeing, the founders decided to establish a state of the art pharmaceutical manufacturing facility to create drugs in accordance to their own strict specifications. As a result of such strong ideals and a passion for welfare, Fahrenheit was born. As such, the visions of our founders can be reflected in the company’s name, PT. Pratapa Nirmala. Adopted from ancient Sanskrit, Pratapa translates to glory while Nirmala means pure. In short, to achieve glory, we need to get customer respect and loyalty, and the only way to achieve this is to sell our products in its purest form, the highest possible quality.

Fahrenheit’s first manufacturing facility was constructed in a major industrial complex in Tangerang, West Java on two hectares of land. Its first commercial batch consisted of cardiovascular drugs and vitamins prepared in simple oral forms. Since then, the plant’s technology and facilities have been continuously upgraded several times to offer only the highest quality products. In 1994, Fahrenheit expanded its manufacturing and added oral and injectable Cephalosporine to its lineup. Another expansion was completed in 1995 to accommodate the manufacturing of small volume parenteral (SVP) and ophthalmic products. Despite the economic crisis of 1998 in Asia, the company aggressively expanded its manufacturing capabilities to develop large volume parenteral products with a focus on antibiotics. Our investment in oral and injectable hormone contraceptive products bore fruit in 2004. A new facility was constructed to accommodate for increased demand of oral and injectable Cephalosporine in 2010. By 2012, the company invested in a larger SVP plant complete with a lyophilized facility. We finished construction of a larger facility for LVP products in 2015 and we are currently building an additional plant for our oral dosage preparations due to be finished in 2017. All of Fahrenheit’s practices comply with the GMP International Standards to develop an assortment of ethical products for cardiovascular, hematopoietic, respiratory, metabolic, alimentary, genitourinary systems, antibiotics and vitamins from simple oral forms two injectable forms including IV solutions. With the company’s wide range of capabilities, it has positioned itself as a major branded generic manufacturing company in Indonesia focusing on specialty products.

 

Management Teams

Dr. Januar Widodo Finasm, SpPD, KGH
Dr. Januar Widodo Finasm, SpPD, KGH

Position

Board of Medical Directors

Dr. Antono Tan, FACCm FSCAI, FAMS
Dr. Antono Tan, FACCm FSCAI, FAMS

Position

Board of Medical Directors
Peter Sutandar
Peter Sutandar

Position

Managing Director
Adi Suherman
Adi Suherman

Position

Director
Fung Mie
Fung Mie

Position

IT Manager
Heru S.
Heru S.

Position

OTC National Sales Manager
Thomas C. K.
Thomas C. K.

Position

OGB Division

Suparjo
Suparjo

Position

Ethical National Sales Manager
Gunawan Kusuma
Gunawan Kusuma

Position

Deputy National Sales Manager
Daniel
Daniel

Position

Finance & Acc Director
John
John

Position

Head of Marketing
Sonny Langi
Sonny Langi

Position

Factory Manager